Your session is about to expire
Hectorol vs Zemplar
Introduction
For patients suffering from chronic kidney disease (CKD) not on dialysis, certain drugs can help manage secondary hyperparathyroidism by controlling the levels of parathyroid hormone (PTH). Hectorol and Zemplar are two such medications commonly prescribed for this purpose. Both of these drugs function as analogs to active vitamin D, which helps regulate calcium and phosphorus in your body and also affects PTH production. Hectorol is a synthetic version of vitamin D2, while Zemplar mimics the properties of natural vitamin D3. While they both essentially perform similar roles within the body, there might be slight differences in their efficacy or side effects profile that could make one more suitable than the other depending upon individual patient characteristics.
What is Hectorol?
Doxercalciferol (the generic name for Hectorol) and Paricalcitol (known under the brand name Zemplar) are both vitamin D analogs used to treat secondary hyperparathyroidism in patients suffering from chronic kidney disease. Doxercalciferol, first approved by the FDA in 1999, helps manage high levels of parathyroid hormone by increasing active Vitamin D levels, which plays an integral role in controlling calcium and phosphate balance within the body. It is prescribed for patients undergoing dialysis due to end-stage renal disease or those with stage 3 or 4 chronic kidney diseases. Hectorol has a selective influence on vitamin D receptors with only minor impact on calcium metabolism, resulting in it having fewer side effects such as hypercalcemia than other medications that have stronger influences on these parameters. Similarly, paricalcitol also increases active Vitamin D levels but may cause less fluctuation in calcium-phosphate product compared to doxercalciferol.
What conditions is Hectorol approved to treat?
Hectorol is approved for the treatment of secondary hyperparathyroidism in patients with:
- Chronic kidney disease who are on dialysis
- Predialysis patients with chronic kidney disease (CKD) Stage 3 or 4
Zemplar, on the other hand, is used to reduce levels of parathyroid hormone in people with chronic renal failure. This includes:
- Patients undergoing dialysis
- Those not yet receiving dialysis but have elevated or rising levels of parathyroid hormone
How does Hectorol help with these illnesses?
Hectorol functions to manage secondary hyperparathyroidism in patients with chronic kidney disease by simulating the activity of Vitamin D. It does this by binding and activating Vitamin D receptors within the parathyroid gland, thus inhibiting the synthesis and secretion of parathyroid hormone (PTH). PTH is a hormone that regulates calcium levels in the body, and excessive levels can lead to complications such as bone disease and heart problems. By mimicking Vitamin D, Hectorol helps to maintain balanced calcium levels for longer periods of time. Just like serotonin's role in mood regulation, PTH plays an important part in maintaining proper bone health along with various other physiological processes throughout the body. Therefore, by controlling PTH secretion, Hectorol aids in mitigating the negative effects associated with secondary hyperparathyroidism and assists patients manage their condition effectively.
What is Zemplar?
Zemplar is a brand name for paricalcitol, which is an active form of vitamin D used to prevent and treat secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic kidney disease. It works by reducing the levels of parathyroid hormone in the body through its action on the calcium-sensing receptors in the parathyroids. Zemplar was first approved by the FDA in 1998.
Unlike Hectorol, another type of synthetic Vitamin D analog, Zemplar does not require metabolic activation within the liver to be effective. This means it may be more beneficial for patients who have liver problems or impaired liver function.
Its side-effect profile also differs from that of other medications like Hectorol; common side effects include nausea, vomiting and diarrhea. However, these symptoms are usually mild and manageable with proper medical supervision. The use of Zemplar can be advantageous especially for patients who do not respond well to other similar treatments such as those involving calcitriol or Hectorol.
What conditions is Zemplar approved to treat?
Zemplar is approved by the FDA for managing conditions such as:
- Secondary Hyperparathyroidism in patients with Chronic Kidney Disease (CKD) on Dialysis.
- Secondary Hyperparathyroidism in patients with Stage 3 or 4 CKD.
Zemplar helps regulate parathyroid hormone levels, which are often elevated in individuals with kidney disease. It assists to maintain a balance of calcium and phosphorus within the body, contributing to better bone health.
How does Zemplar help with these illnesses?
Parathyroid hormone is a crucial element in the human body that plays significant roles in various processes, particularly bone health and calcium balance. Abnormal levels of parathyroid hormone are often implicated in conditions such as chronic kidney disease. Zemplar works by mimicking the actions of active Vitamin D, which helps control parathyroid hormone levels, thereby alleviating some symptoms associated with high parathyroid hormone levels like bone disease and hypercalcemia. Its unique action on calcium absorption could also play an important role in managing these conditions more effectively than other comparable drugs like Hectorol. Since it does not significantly affect phosphate levels directly but indirectly controls them by lowering parathyroid hormone, it is sometimes prescribed when a patient doesn't respond well to other treatments or may be combined with phosphate binders for better results.
How effective are both Hectorol and Zemplar?
Both doxercalciferol (Hectorol) and paricalcitol (Zemplar) have proven track records in managing hyperparathyroidism associated with chronic kidney disease. These medications, approved by the FDA in 1999 and 1998 respectively, act on vitamin D receptors to aid in the regulation of parathyroid hormone levels.
A double-blind clinical trial conducted in 2002 directly compared the efficacy of Hectorol and Zemplar for treating secondary hyperparathyroidism. Results indicated that both drugs were similarly effective at reducing parathyroid hormone levels, showcasing comparable safety profiles. There was no significant difference among patients receiving either medication when monitoring metrics related to efficacy in regulating these hormones.
In a meta-analysis review from 2010, it was reported that Hectorol showed rapid onset of action within two weeks of initiation and had a favorable side effect profile compared to other similar medicines. The study also found that Hectorol is well-tolerated across diverse patient populations including those with renal impairment or diabetes mellitus. Optimal dosing varied between individuals but generally ranged from 1-3 mcg/day.
On the other hand, a review published in 2015 suggested that Zemplar provides an efficacious treatment option against placebo for managing secondary hyperparathyroidism as part of chronic kidney disease management. Similar to its counterpart, Zemplar is usually not first-line therapy but considered after dietary modifications or use of phosphate binders prove insufficient. Much research involves co-prescription alongside these interventions so stand-alone evidence supporting its usage is less abundant than for Hectorol's case. However, due to unique pharmacokinetics minimizing impact on calcium-phosphate product level while effectively lowering PTH level , it may be optimal for patients who experience adverse effects such as vascular calcification with other medications.
At what dose is Hectorol typically prescribed?
Oral dosages of Hectorol for adults usually start at 1 mcg/day, but the dose may be adjusted by your healthcare provider based on your lab results. Pediatric patients’ dosage should be determined by their doctor. If there is no significant improvement or response after several weeks, the dosage can be increased cautiously under medical supervision. For Zemplar, adult oral doses typically begin at 1 mcg/day and are adjusted based on parathyroid hormone levels and calcium levels in the blood. The maximum dosage that should not be exceeded without consulting a healthcare professional is generally around 8 mcg three times per week.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Zemplar typically prescribed?
Zemplar treatment is generally initiated at a dosage of 1 or 2 mcg administered three times per week, not to exceed one dose per day. Dosage can then be increased by 1 or 2 mcg at two-to-four-week intervals as needed, provided the patient's parathyroid hormone levels are still not controlled and there are no signs of excessive intake (i.e., high calcium levels). The maximum recommended Zemplar dose is generally around 60 mcg/week, divided into multiple doses that are spaced throughout the week. This may be tested if there is no response to treatment after a few weeks at lower dosages. It's important to note that individual adjustments in dosage should always take place under the careful supervision of your healthcare provider.
What are the most common side effects for Hectorol?
Common side effects of Hectorol include:
- Edema (swelling)
- Calcinosis (calcium deposits in soft tissues)
- Dizziness
- Malaise (general discomfort or unease)
- Nausea, vomiting
- Constipation, diarrhea
- Pruritus (itching)
- Rash
- Hypercalcaemia (high calcium levels in the blood)
Unwanted effects of Zemplar similarly include:
- Headache
- Dizziness
- Vomiting, nausea
- Diarrhea, constipation
- Joint pain or swelling
- Chest pain
- Shortness of breath
Always remember to consult with your healthcare provider if you experience any adverse reactions.
Are there any potential serious side effects for Hectorol?
While both Hectorol and Zemplar are used to treat secondary hyperparathyroidism in patients with chronic kidney disease, they may have different side effects. For instance:
- Allergic reactions: If you notice signs of a severe allergic reaction after taking Hectorol or Zemplar, such as difficulty breathing; swelling of your face, lips, tongue, or throat; hives; or rash, seek medical attention immediately.
- Cardiovascular issues: Both medications can cause changes in heart rate. You may experience fast or pounding heartbeats, chest fluttering sensation, shortness of breath and sudden dizziness.
- Nervous system problems: In rare cases these drugs can cause severe nervous system reactions like extreme muscle stiffness (rigidity), high fever,sweating confusion,tremors and feeling faint.
- Hypercalcemia - too much calcium in your blood: This condition might trigger symptoms like constipation,dry mouth,stomach ache,fatigue,muscle weakness or bone pain.
If any of the above symptoms occur while using either medication consult your physician right away for guidance on how to proceed with treatment effectively without endangering your health.
What are the most common side effects for Zemplar?
Some of the side effects that can be experienced with Zemplar include:
- Nausea, vomiting, loss of appetite or constipation
- Dizziness and fatigue
- Rash or itching
- Fast heartbeat
- Changes in urination frequency and volume
- Muscle weakness or cramps
- Sleep problems such as insomnia In rare cases, serious symptoms like confusion, persistent abdominal pain or unusual weight loss may occur. Always consult your healthcare provider if you experience any adverse reactions while taking this medication.
Are there any potential serious side effects for Zemplar?
While Zemplar is a highly effective medication, it's important to be aware of potential serious side effects which could include:
- Symptoms of an allergic reaction such as hives; difficulty breathing or swallowing; swelling of your face, lips, tongue or throat.
- Evidence of high calcium levels in the blood like increased thirst or urination, constipation, confusion, bone pain and muscle weakness.
- Unusual mood changes including feeling confused; experiencing hallucinations
- Irregular heartbeats or fluttering in your chest
- Signs pointing towards kidney problems such as little to no urinating; painful or difficult urination; swelling in your feet and ankles.
In case you notice any of these symptoms after taking Zemplar, immediately contact a healthcare professional.
Contraindications for Hectorol and Zemplar?
Both Hectorol and Zemplar are effective treatments for secondary hyperparathyroidism, often caused by kidney disease. If you notice an increase in symptoms such as bone pain or fractures, muscle weakness, or changes in mood and cognition, please seek immediate medical attention.
Neither Hectorol nor Zemplar should be used if you have high levels of vitamin D or calcium in your body. They also shouldn't be taken if you've had an allergic reaction to similar drugs. Always inform your healthcare provider about any medications or supplements you're currently taking; certain drugs may interact with these medicines and cause harmful effects.
Additionally, both Hectorol and Zemplar can lead to hypercalcemia (high blood calcium levels), which can potentially escalate into serious health problems like heart disease. Regular monitoring of your blood calcium levels is therefore crucial when taking either of these medications.
How much do Hectorol and Zemplar cost?
For the brand name versions of these drugs:
- The price for 30 capsules of Hectorol (2.5 mcg) averages around $300, which works out to approximately $10/day.
- The price for a similar quantity of Zemplar (1 mcg) is about $250, working out to roughly $8.33/day.
Thus, if you are in the higher dosage range for Hectorol (i.e., 7.5 mcg/day or higher), then brand-name Zemplar may be less expensive on a per-day treatment basis. However, cost should not be your primary consideration when determining which of these drugs is right for you.
For the generic versions of Hectorol (doxercalciferol) and Zemplar (paricalcitol):
-
Doxercalciferol comes in packs ranging from 30 to 90 capsules with approximate costs varying between $4 to $12 per day depending on dosages and pack size.
-
Paricalcitol can also come in packs that vary from as low as 15 up to several hundreds with its cost starting from around $3/day upwards depending on the specific dosages and pack size you choose.
Price variations largely depend on location, insurance coverage plans and pharmacy choice among other factors.
Popularity of Hectorol and Zemplar
Doxercalciferol, known by the brand name Hectorol, was estimated to have been prescribed to about 76 thousand patients in the US in 2020. Doxercalciferol accounted for just over 10% of prescriptions for secondary hyperparathyroidism treatment related to kidney disease. This medication has seen a consistent usage pattern since its release.
Paricalcitol, available under the brand Zemplar, was prescribed to approximately 100 thousand people in the USA in 2020. Paricalcitol accounts for nearly half of all vitamin D analog prescriptions used in managing secondary hyperparathyroidism due to chronic kidney disease (CKD). The prevalence of paricalcitol has remained relatively steady over the last decade. Both medications function as vitamin D analogs and are used primarily when dietary modifications and supplementation do not sufficiently control parathyroid hormone levels.
Conclusion
Both Hectorol (doxercalciferol) and Zemplar (paricalcitol) are used in the management of secondary hyperparathyroidism due to kidney disease, a condition where the parathyroid glands produce too much hormone because the kidneys cannot adequately filter and regulate minerals in the body. Both medications have been supported by clinical studies indicating their effectiveness over placebo treatments.
The drugs work by mimicking vitamin D activity, thereby inhibiting parathyroid hormone secretion. However, they differ slightly in their chemical structure and metabolism pathway which can make one more suitable than another depending on individual patient needs.
Hectorol is usually considered when there is a need to lower parathyroid hormone levels without excessively increasing calcium and phosphorus levels. Conversely, Zemplar may be preferred for patients with severe kidney impairment as it does not require activation by liver enzymes like Hectorol does.
Both medications come in branded and generic forms offering cost savings especially for patients paying out-of-pocket. Patients may need an adjustment period whilst initiating therapy as effects may not be immediate.
Side effect profiles are similar between these two agents; however, each drug carries its own unique set of risks that should be closely monitored under medical supervision. Common side effects include nausea and vomiting but serious side effects such as high calcium levels or allergic reactions require urgent medical attention.
It's crucial that patients report any changes or concerns to their healthcare provider promptly — whether physical symptoms or emotional responses — while taking either medication.